Sean A. McCarthy, CEO at CytomX Therapeutics, Inc. (CTMX), sold 37,656 shares at $0.60 ($23K) on 2025-03-18, disclosed to the SEC on 2025-03-20.
Open-market sale of $23k CTMX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTMX | SELL | 2025-11-10 | $924K | — | Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $17K | — | Filing → |